Latino Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) and COPEGUS (Ribavirin) in Treatment-Naive Patients With Chronic Hepatitis C-Genotype 1.

ClinicalTrials.gov ID: NCT00107653

Public ClinicalTrials.gov record NCT00107653. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Oct 20, 2026, 4:08 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective, Multicenter, Open-label, Comparative, Efficacy Study of Pegasys® Plus Copegus® in Treatment-naïve Latino Patients With Chronic Hepatitis C-genotype 1, as Compared to Treatment-naïve Non- Latino Caucasian Patients With Chronic Hepatitis C-genotype 1

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This single arm study will evaluate the efficacy and safety of PEGASYS (180 micrograms sc weekly) plus ribavirin (1000-1200mg po daily) in treatment-naive Latino patients versus non-Latino Caucasian patients with chronic hepatitis C- genotype 1. The anticipated time on study treatment is 3-12 months and the target sample size is 500+ patients.

Study identification

NCT ID: NCT00107653
Recruitment status: Completed
Study type: Interventional
Phase: Phase 4
Lead sponsor: Hoffmann-La Roche; Industry
Enrollment: 569 participants

Conditions and interventions

Conditions

Hepatitis C, Chronic

Interventions

Ribavirin Drug
Peginterferon alfa-2a Drug

Drug

Eligibility (public fields only)

Age range: 18 Years to 65 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Oct 2004 (Type not available)
Primary completion: Sep 2007 (Actual)
Completion: Sep 2007 (Actual)
Last update posted: Jun 21, 2016

2004 – 2007

United States locations

U.S. sites: 58
U.S. states: 20
U.S. cities: 49

Facility	City	State	ZIP	Site status
Not listed	Scottsdale	Arizona	85259	—
Not listed	Tucson	Arizona	85712	—
Not listed	Anaheim	California	92801	—
Not listed	Fountain Valley	California	92708	—
Not listed	Fresno	California	93721	—
Not listed	Lancaster	California	93534	—
Not listed	Los Angeles	California	90022	—
Not listed	Los Angeles	California	90033	—
Not listed	Los Angeles	California	90095	—
Not listed	Palo Alto	California	94304-1509	—
Not listed	Redlands	California	92373	—
Not listed	Sacramento	California	95817	—
Not listed	San Bernardino	California	92404	—
Not listed	San Diego	California	92103-8465	—
Not listed	San Diego	California	92123	—
Not listed	San Diego	California	92154	—
Not listed	San Diego	California	92161	—
Not listed	San Francisco	California	94110	—
Not listed	San Luis Obispo	California	93401	—
Not listed	Ventura	California	93003	—
Not listed	Pueblo	Colorado	81008	—
Not listed	Boca Raton	Florida	33428	—
Not listed	Bradenton	Florida	34209	—
Not listed	Miami	Florida	33125	—
Not listed	North Miami Beach	Florida	33162	—
Not listed	Plantation	Florida	33324	—
Not listed	Austell	Georgia	30106	—
Not listed	Chicago	Illinois	60612	—
Not listed	Chicago	Illinois	60637	—
Not listed	Gurnee	Illinois	60031	—
Not listed	Indianapolis	Indiana	46202	—
Not listed	Baton Rouge	Louisiana	70890	—
Not listed	New Orleans	Louisiana	70115	—
Not listed	Baltimore	Maryland	21205	—
Not listed	Framingham	Massachusetts	01702	—
Not listed	Worcester	Massachusetts	01655	—
Not listed	St Louis	Missouri	63110	—
Not listed	Vineland	New Jersey	08360	—
Not listed	Bayside	New York	11358	—
Not listed	New York	New York	10029	—
Not listed	Rochester	New York	14618	—
Not listed	Chapel Hill	North Carolina	27599-7584	—
Not listed	Fayetteville	North Carolina	28304	—
Not listed	Philadelphia	Pennsylvania	19107	—
Not listed	Philadelphia	Pennsylvania	19141	—
Not listed	Nashville	Tennessee	37211	—
Not listed	Dallas	Texas	75203	—
Not listed	Fort Sam Houston	Texas	78234-3879	—
Not listed	Fort Worth	Texas	76107	—
Not listed	Galveston	Texas	77555	—
Not listed	Houston	Texas	77030	—
Not listed	Houston	Texas	77090	—
Not listed	San Antonio	Texas	78215	—
Not listed	San Antonio	Texas	78258	—
Not listed	Salt Lake City	Utah	84121	—
Not listed	Fairfax	Virginia	22031	—
Not listed	Seattle	Washington	98133	—
Not listed	Tacoma	Washington	98405	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00107653, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jun 21, 2016 · Synced Oct 20, 2026

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00107653 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →